https://acureinsight.org/?page_id=13 2026-08-20T15:10:20+00:00 https://acureinsight.org/childhood-eye-cancer-not-just-ocular-melanoma/ 2021-03-11T17:09:28+00:00 https://acureinsight.org/wp-content/uploads/2021/03/images-9.jpeg https://acureinsight.org/wp-content/uploads/2021/03/images-9.jpeg https://acureinsight.org/2019-eye-believe-survivorship-seminar/ 2021-03-11T17:16:59+00:00 https://acureinsight.org/wp-content/uploads/2021/03/survivorship-seminar2019.jpg https://acureinsight.org/wp-content/uploads/2021/03/survivorship-seminar2019-300x182.jpg https://acureinsight.org/1350-2/ 2021-04-01T03:43:14+00:00 https://acureinsight.org/wp-content/uploads/2021/03/need-image-sml-300x182.jpg https://acureinsight.org/eye-believe-survivorship-seminar-october-8-10-2020/ 2021-06-01T03:21:02+00:00 https://acureinsight.org/wp-content/uploads/2021/03/survivorship-seminar2020thm.jpg https://acureinsight.org/wp-content/uploads/2021/03/survivorship-seminar2020-232x300.jpg https://acureinsight.org/2044-2/ 2021-08-18T21:07:42+00:00 https://acureinsight.org/wp-content/uploads/2021/08/linnaeus_logo_new.jpg https://acureinsight.org/3389-2/ 2021-12-10T18:41:52+00:00 https://acureinsight.org/wp-content/uploads/2021/11/JIngle-Mingle-Tee-event.jpg https://acureinsight.org/wp-content/uploads/2021/11/Jingle-Mingle-Mug-2021-event.jpg https://acureinsight.org/wp-content/uploads/2021/11/JIngle-Mingle-Tee-event.jpg https://acureinsight.org/world-cancer-day/ 2022-02-04T18:25:49+00:00 https://acureinsight.org/wp-content/uploads/2022/02/273206946_5026883367351574_1819410372611149445_n.png https://acureinsight.org/3634-2/ 2022-04-01T17:13:05+00:00 https://acureinsight.org/wp-content/uploads/2022/03/277572395_5177044572335452_121970743794375525_n-300x251.jpg https://acureinsight.org/eyepatchday/ 2022-05-04T15:28:20+00:00 https://acureinsight.org/wp-content/uploads/2022/05/april-newsletter-save-the-date.png https://acureinsight.org/wp-content/uploads/2022/05/april-newsletter-save-the-date.png https://acureinsight.org/arvo-2022/ 2022-05-30T22:56:44+00:00 https://acureinsight.org/may-is-melanoma-awareness-and-healthy-vision-month/ 2022-05-30T22:57:08+00:00 https://acureinsight.org/highlights-for-asco-2022/ 2022-06-27T20:35:43+00:00 https://acureinsight.org/insight-registry-instructions/ 2022-06-29T01:14:21+00:00 https://acureinsight.org/2022-isoo-recap/ 2022-07-31T22:24:53+00:00 https://acureinsight.org/good-grief-a-pathway-to-healing/ 2022-08-24T17:42:43+00:00 https://acureinsight.org/european-society-of-medical-oncology-esmo-abstracts/ 2022-09-22T16:18:35+00:00 https://acureinsight.org/iran-cancer-rare-ocular-melanoma/ 2023-01-23T16:37:31+00:00 https://acureinsight.org/9784-2/ 2023-01-30T18:27:43+00:00 https://acureinsight.org/wp-content/uploads/2023/01/SwinghForACure-rev3-232x300.png https://acureinsight.org/9792-2/ 2023-01-30T18:49:36+00:00 https://acureinsight.org/wp-content/uploads/2023/01/swing-front.png https://acureinsight.org/wp-content/uploads/2023/01/SwinghForACure-rev3-2-232x300.png https://acureinsight.org/wp-content/uploads/2023/01/swqing-back.png https://acureinsight.org/ideaya-announces-promising-phase-2-clinical-trial/ 2023-02-09T16:38:20+00:00 https://acureinsight.org/wp-content/uploads/2023/02/ideaya-image.png https://acureinsight.org/10302-2/ 2023-05-24T14:54:43+00:00 https://acureinsight.org/wp-content/uploads/2023/05/4.30-Omie-Cook-Book-post-e1684940060601.png https://acureinsight.org/newsworthy-notes-from-asco/ 2023-06-16T17:51:33+00:00 https://acureinsight.org/wp-content/uploads/2023/06/ASCO-picture.jpg https://acureinsight.org/foghorn-therapeutics-announces-clinical-data-from-phase-1-study-of-fhd-286-in-metastatic-uveal-melanoma/ 2023-06-28T22:11:27+00:00 https://acureinsight.org/wp-content/uploads/2023/06/foghorn-logo.jpeg https://acureinsight.org/castle-biosciences-publish-genetic-profile-data/ 2023-07-25T18:25:39+00:00 https://acureinsight.org/wp-content/uploads/2023/07/CastleLogoColor.png https://acureinsight.org/aura-biosciences-phase-3-trial-for-choroidal-melanoma/ 2023-11-13T22:12:13+00:00 https://acureinsight.org/wp-content/uploads/2023/11/aura-logo.png https://acureinsight.org/wp-content/uploads/2023/11/aura-logo.png https://acureinsight.org/eye-on-coog-an-eye-believe-mini-seminar/ 2023-12-22T17:21:43+00:00 https://acureinsight.org/wp-content/uploads/2023/12/Eye-on-COOG-Jan-6-mini-seminar-3.png https://acureinsight.org/wp-content/uploads/2023/12/Eye-on-COOG-Jan-6-mini-seminar-3-1024x576.png https://acureinsight.org/new-studies-published-in-bmj-journals/ 2023-12-23T17:51:46+00:00 https://acureinsight.org/wp-content/uploads/2023/11/Interesting-studies-to-check-out.png https://acureinsight.org/wp-content/uploads/2023/11/Interesting-studies-to-check-out-300x300.png https://acureinsight.org/enhanced-staging-of-choroidal-melanomas-and-ciliary-body-tumor-volume-estimation-and-competing-risk-analyses/ 2023-12-23T17:53:03+00:00 https://acureinsight.org/wp-content/uploads/2023/12/enhanced-staging-article.png https://acureinsight.org/wp-content/uploads/2023/12/enhanced-staging-article-300x300.png https://acureinsight.org/trisalus-life-sciences-announces-cms-reimbursement-for-the-trinav-infusion-system/ 2023-12-23T17:53:53+00:00 https://acureinsight.org/wp-content/uploads/2023/12/BREAKING-NEWS.png https://acureinsight.org/wp-content/uploads/2023/12/BREAKING-NEWS.png https://acureinsight.org/improved-prediction-of-metastasis-using-tumor-volume/ 2023-12-23T17:56:15+00:00 https://acureinsight.org/wp-content/uploads/2023/11/AAO2021.png https://acureinsight.org/wp-content/uploads/2023/11/AAO2021.png https://acureinsight.org/aura-biosciences-phase-3-trial-for-choroidal-melanoma-2/ 2023-12-23T17:58:19+00:00 https://acureinsight.org/wp-content/uploads/2023/12/1.png https://acureinsight.org/wp-content/uploads/2023/12/1.png https://acureinsight.org/acis-attends-global-meeting-at-society-for-melanoma-research/ 2023-12-23T18:04:34+00:00 https://acureinsight.org/wp-content/uploads/2023/11/Picture1.png https://acureinsight.org/wp-content/uploads/2023/11/Picture1.png https://acureinsight.org/biobank-insight-registry-collaboration-by-acis-and-honorhealth/ 2023-12-23T18:05:20+00:00 https://acureinsight.org/ioo-in-palo-alto-dec-2023/ 2023-12-27T01:33:13+00:00 https://acureinsight.org/wp-content/uploads/2023/12/IMG_7180-scaled.jpg https://acureinsight.org/wp-content/uploads/2023/12/IMG_7180-300x225.jpg https://acureinsight.org/ionctura-clinical-trial-news/ 2023-12-27T01:35:21+00:00 https://acureinsight.org/wp-content/uploads/2023/12/ionctura-.png https://acureinsight.org/wp-content/uploads/2023/12/ionctura--300x300.png https://acureinsight.org/december-lookin-for-a-cure/ 2023-12-27T01:58:49+00:00 https://acureinsight.org/wp-content/uploads/2023/12/JV101991-scaled.jpg https://acureinsight.org/wp-content/uploads/2023/12/20231210_5kHoustonTX_0163-300x200.jpg https://acureinsight.org/steps-for-sight-2024-is-open/ 2024-01-06T17:33:43+00:00 https://acureinsight.org/wp-content/uploads/2023/12/steps-for-sight-end-screen-1.png https://acureinsight.org/wp-content/uploads/2023/12/Steps-for-sight-FLYER-2024-225x300.png https://acureinsight.org/chcs-clues-to-metastases-from-oshu/ 2024-01-08T22:04:20+00:00 https://acureinsight.org/wp-content/uploads/2024/01/1.8.24CHC-article-Alison-Skalet.png https://acureinsight.org/wp-content/uploads/2024/01/1.8.24CHC-article-Alison-Skalet-300x300.png https://acureinsight.org/eyeonmentalhealth2024/ 2024-01-13T00:34:54+00:00 https://acureinsight.org/wp-content/uploads/2024/01/ZOOM-banner.png https://acureinsight.org/wp-content/uploads/2024/01/ZOOM-banner-1024x576.png https://acureinsight.org/whoistscan/ 2024-01-16T17:29:02+00:00 https://acureinsight.org/wp-content/uploads/2024/01/BIO-company-interview-banners-blog-posts.png https://acureinsight.org/wp-content/uploads/2024/01/BIO-company-interview-banners-blog-posts.png https://acureinsight.org/exciting-news-from-delcath/ 2024-01-16T17:38:24+00:00 https://acureinsight.org/wp-content/uploads/2024/01/Breaking-news-Delcath-300x300.png https://acureinsight.org/5ksfloridarecap/ 2024-01-22T20:31:16+00:00 https://acureinsight.org/wp-content/uploads/2024/01/N2_6318-scaled.jpg https://acureinsight.org/wp-content/uploads/2024/01/N2_6318-300x200.jpg https://acureinsight.org/fda-approved-treatment-update/ 2024-01-25T21:25:16+00:00 https://acureinsight.org/wp-content/uploads/2024/01/1.png https://acureinsight.org/wp-content/uploads/2024/01/1-300x300.png https://acureinsight.org/wp-content/uploads/2024/01/1-1-1024x512.png https://acureinsight.org/wp-content/uploads/2024/01/2-1-1024x512.png https://acureinsight.org/small-choroidal-melanoma-check-this-out/ 2024-01-25T21:35:58+00:00 https://acureinsight.org/wp-content/uploads/2024/01/Aura-Bio-Phase-III-clin.-trial-alert-1.png https://acureinsight.org/wp-content/uploads/2024/01/Aura-Bio-Phase-III-clin.-trial-alert-1-1024x1024.png https://acureinsight.org/acisjennnewhire/ 2024-01-31T17:22:27+00:00 https://acureinsight.org/wp-content/uploads/2024/01/Untitled-design.png https://acureinsight.org/wp-content/uploads/2024/01/Untitled-design-1024x1024.png https://acureinsight.org/tscanstudysitesupdate/ 2024-02-10T23:50:34+00:00 https://acureinsight.org/wp-content/uploads/2024/01/1-2.png https://acureinsight.org/wp-content/uploads/2024/01/3-2-1024x512.png https://acureinsight.org/wp-content/uploads/2024/01/4-2-1024x512.png https://acureinsight.org/wp-content/uploads/2024/01/BIO-company-interview-banners-blog-posts-1.png https://acureinsight.org/wp-content/uploads/2024/01/1-2-1024x1024.png https://acureinsight.org/melanomaexchangepatientforum/ 2024-02-22T21:43:37+00:00 https://acureinsight.org/wp-content/uploads/2024/02/IMG_2333.jpeg https://acureinsight.org/wp-content/uploads/2024/02/IMG_2333-1024x768.jpeg https://acureinsight.org/ocularmelanomapatientstories/ 2024-02-22T21:46:38+00:00 https://acureinsight.org/wp-content/uploads/2024/02/blog-banner-narrow-1.png https://acureinsight.org/wp-content/uploads/2024/02/blog-banner-narrow-1-1024x427.png https://acureinsight.org/wp-content/uploads/2024/02/Kimberly-Sharp-2_24-DONE-1024x1024.png https://acureinsight.org/wp-content/uploads/2024/02/peggy-mcpherin-1024x1024.png https://acureinsight.org/novelmetastatictreatmentocularmelanoma/ 2024-02-22T23:20:05+00:00 https://acureinsight.org/wp-content/uploads/2024/02/Clinical-Trial-Alert-IDEAYA.png https://acureinsight.org/wp-content/uploads/2024/02/Clinical-Trial-Alert-IDEAYA-1024x1024.png https://acureinsight.org/fda-approved-liver-directed-therapy-update/ 2024-02-29T01:06:44+00:00 https://acureinsight.org/wp-content/uploads/2024/02/Breaking-news-Delcath.png https://acureinsight.org/wp-content/uploads/2024/02/Breaking-news-Delcath-1024x1024.png https://acureinsight.org/novel-replimune-rp2-treatment-for-metastatic-uveal-melanoma/ 2024-02-29T01:23:08+00:00 https://acureinsight.org/wp-content/uploads/2024/02/Breaking-News-Delcath-2.png https://acureinsight.org/wp-content/uploads/2024/02/Breaking-News-Delcath-2-1024x1024.png https://acureinsight.org/lookin-for-a-cure-5k-tampa-community-support-for-ocular-melanoma-awareness-tampa-charity-run-ocular-melanoma-supporting-ocular-melanoma-research-in-tampa-impact-of-fundraisi/ 2024-04-30T13:18:58+00:00 https://acureinsight.org/wp-content/uploads/2024/03/Looking-for-a-Cure-11-300x200.jpg https://acureinsight.org/research-updates-in-ocular-melanoma-from-asco-2024/ 2024-07-17T21:22:49+00:00 https://acureinsight.org/replimune-presents-positive-data/ 2024-07-17T21:24:45+00:00 https://acureinsight.org/promising-pathway-act-s-4426-cloned/ 2024-07-17T21:32:19+00:00 https://acureinsight.org/wp-content/uploads/2024/06/The-Senate-Aging-Committee-hearing-on-Promising-Pathway-Act.jpg https://acureinsight.org/wp-content/uploads/2024/06/Mike-brawun-us-senator-300x57.png https://acureinsight.org/wp-content/uploads/2024/06/Mike-brawun-us-senator-promissing-pathway-act-226x300.png https://acureinsight.org/wp-content/uploads/2024/06/The-Senate-Aging-Committee-hearing-on-Promising-Pathway-Act-300x223.jpg https://acureinsight.org/wp-content/uploads/2024/06/Bill-would-allow-treatment-for-terminally-ill-before-FDA-approval-300x165.png https://acureinsight.org/wp-content/uploads/2024/06/promising-pathway-endorsements.png https://acureinsight.org/pediatric-ocular-melanoma-survivor/ 2024-09-05T18:52:59+00:00 https://acureinsight.org/wp-content/uploads/2024/09/IMG_0238.jpeg https://acureinsight.org/wp-content/uploads/2024/09/IMG_0240.jpeg https://acureinsight.org/wp-content/uploads/2024/09/IMG_0239.jpeg https://acureinsight.org/wp-content/uploads/2024/09/IMG_0238.jpeg https://acureinsight.org/esmo-recap-ocular-melanoma/ 2024-10-28T02:33:31+00:00 https://acureinsight.org/wp-content/uploads/2024/09/ESMO-Photo-Sept2024-scaled.jpg https://acureinsight.org/wp-content/uploads/2024/09/Picture1.jpg https://acureinsight.org/wp-content/uploads/2024/03/ACIS-Logo-web.png https://acureinsight.org/wp-content/uploads/2024/09/ESMO-Photo-Sept2024-scaled.jpg https://acureinsight.org/ocular-melanoma-research-ideaya-biosciences-announcement/ 2025-01-15T13:54:09+00:00 https://acureinsight.org/wp-content/uploads/2025/01/ocular-melanoma-Metastatic-Uveal-Melanoma.jpg https://acureinsight.org/wp-content/uploads/2025/01/ocular-melanoma-Metastatic-Uveal-Melanoma.jpg https://acureinsight.org/faces-of-om/ 2025-02-28T00:47:59+00:00 https://acureinsight.org/2025-rare-disease-day-hill-day-and-mra-scientific-meeting/ 2025-03-03T17:03:55+00:00 https://acureinsight.org/wp-content/uploads/2025/03/IMG_4018.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_4018-300x225.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_4017-300x240.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_6916-225x300.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_3998-2-225x300.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_4015-300x300.jpg https://acureinsight.org/wp-content/uploads/2025/03/Resized_20250226_182200_1740612242093-300x135.jpeg https://acureinsight.org/wp-content/uploads/2025/03/Image-1-300x225.jpeg https://acureinsight.org/wp-content/uploads/2025/03/IMG_0233-2-225x300.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_0211-2-225x300.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_6126-225x300.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_4007-300x225.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_4004-225x300.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_4012-225x300.jpg https://acureinsight.org/wp-content/uploads/2025/03/IMG_4006-225x300.jpg https://acureinsight.org/acis-at-asco-2025-uveal-melanoma-abstracts-and-sessions/ 2025-06-19T02:18:39+00:00 https://acureinsight.org/wp-content/uploads/2025/06/uveal-melanoma-mutations-a-cure-in-sight.jpg https://acureinsight.org/wp-content/uploads/2025/06/ASCO-annual-meeting-ocular-melanoma.jpg https://acureinsight.org/wp-content/uploads/2025/06/uveal-melanoma-mutations-a-cure-in-sight.jpg https://acureinsight.org/wp-content/uploads/2025/06/ocular-melanoma.jpg https://acureinsight.org/a-grateful-acknowledgment-from-a-cure-in-sight-ocular-melanoma/ 2025-06-19T02:18:50+00:00 https://acureinsight.org/wp-content/uploads/2025/06/Thank-you-A-Cure-In-Sight-Ocular-Melanoma.jpg https://acureinsight.org/wp-content/uploads/2025/06/Thank-you-A-Cure-In-Sight-Ocular-Melanoma.jpg https://acureinsight.org/a-cure-in-sight-to-exhibit-at-2025-asco-annual-meeting/ 2025-06-19T02:18:52+00:00 https://acureinsight.org/wp-content/uploads/2025/06/ASCO-Annual-Meeting-a-cure-in-sight.jpg https://acureinsight.org/wp-content/uploads/2025/06/ASCO-Annual-Meeting-a-cure-in-sight.jpg https://acureinsight.org/a-cure-in-sight-participates-in-the-2025-hilliard-seigler-duke-melanoma-consortium-to-advocate-for-ocular-melanoma-awareness/ 2025-06-19T02:18:54+00:00 https://acureinsight.org/wp-content/uploads/2025/06/Hilliard-Seigler-Duke-Melanoma-Consortium-Ocular-Melanoma-A-Cure-In-Sight.jpg https://acureinsight.org/wp-content/uploads/2025/06/Hilliard-Seigler-Duke-Melanoma-Consortium-Ocular-Melanoma-A-Cure-In-Sight.jpg https://acureinsight.org/a-cure-in-sight-at-aacr-2025-advancing-uveal-melanoma-research/ 2025-06-19T02:18:55+00:00 https://acureinsight.org/wp-content/uploads/2025/06/A-Cure-In-Sight-at-AACR-Ocular-Melanoma.jpg https://acureinsight.org/wp-content/uploads/2025/06/A-Cure-In-Sight-at-AACR-Ocular-Melanoma.jpg https://acureinsight.org/a-cure-in-sight-creating-the-first-awareness-ribbon-for-ocular-melanoma/ 2025-07-03T03:24:41+00:00 https://acureinsight.org/wp-content/uploads/2025/07/OM-support-ribbon.jpg https://acureinsight.org/wp-content/uploads/2025/07/OM-support-ribbon-300x300.jpg https://acureinsight.org/how-rp1s-fda-rejection-affects-access-to-innovative-treatments-for-ocular-melanoma/ 2025-07-23T15:55:05+00:00 https://acureinsight.org/wp-content/uploads/2025/07/ocular-melanoma-FDA-IGNYTE-scaled.jpg https://acureinsight.org/wp-content/uploads/2025/07/ocular-melanoma-FDA-IGNYTE-1024x579.jpg https://acureinsight.org/sponsor-eye-believe-survivorship-seminar/ 2025-07-29T22:08:14+00:00 https://acureinsight.org/wp-content/uploads/2025/07/2025-eye-believe-Raleigh-NC.png https://acureinsight.org/wp-content/uploads/2025/07/2025-eye-believe-Raleigh-NC.png https://acureinsight.org/acis-releases-new-uveal-melanoma-clinical-trials-summary-a-comprehensive-tool-for-patients-and-providers/ 2025-07-31T02:38:27+00:00 https://acureinsight.org/wp-content/uploads/2025/07/ACIS-Logo-Full-pantone-Mod2000x2000-e1753923808746.jpg https://acureinsight.org/wp-content/uploads/2025/07/ACIS-Logo-Full-pantone-Mod2000x2000-e1753923808746.jpg https://acureinsight.org/breakthrough-yttrium-90-radiation-therapy-for-ocular-melanoma-now-available-at-meeth/ 2025-08-10T18:33:10+00:00 https://acureinsight.org/wp-content/uploads/2025/07/ACIS-Logo-Full-pantone-Mod2000x2000-e1753923808746.jpg https://acureinsight.org/wp-content/uploads/2025/08/ocular-melanoma-eye-cancer-treatment-300x205.jpg https://acureinsight.org/a-cure-in-sight-launches-the-insight-biobank-partners-with-pattern-org-to-make-progress-possible/ 2025-09-17T03:31:17+00:00 https://acureinsight.org/wp-content/uploads/2025/09/biobank-_ACISxRCRF_logo.png https://acureinsight.org/wp-content/uploads/2025/09/biobank-_ACISxRCRF_logo.png https://acureinsight.org/uniting-patients-and-accelerating-research-a-new-chapter-launches-for-a-cure-in-sight-and-rcrf/ 2025-09-17T03:38:41+00:00 https://acureinsight.org/wp-content/uploads/2025/09/biobank-_ACISxRCRF_logo.png https://acureinsight.org/wp-content/uploads/2025/09/biobank-_ACISxRCRF_logo.png https://acureinsight.org/replimune-announces-fda-acceptance-of-bla-resubmission-of-rp1-for-the-treatment-of-advanced-melanoma/ 2025-10-29T13:00:59+00:00 https://acureinsight.org/wp-content/uploads/2025/10/Replimune_logo-scaled.jpg https://acureinsight.org/wp-content/uploads/2025/10/Replimune_logo-1024x205.jpg https://acureinsight.org/a-cure-in-sight-attends-esmo-2025-as-new-prame-targeted-t-cell-therapy-demonstrates-durable-responses-in-metastatic-uveal-melanoma/ 2025-10-29T13:10:46+00:00 https://acureinsight.org/wp-content/uploads/2025/10/ESMO-2025.jpg https://acureinsight.org/wp-content/uploads/2025/10/ESMO-2025.jpg https://acureinsight.org/ocular-melanoma-the-future-dr-deborah-bartons-approach-with-t-scan-therapeutics/ 2025-10-29T13:25:08+00:00 https://acureinsight.org/wp-content/uploads/2024/02/DALL%C2%B7E-2024-02-22-19.01.30-A-warm-and-approachable-medical-oncologist-engaged-in-conversation-with-a-hopeful-expression-symbolizing-Dr.-Deborah-Bartons-patient-focused-approa.webp https://acureinsight.org/servier-and-ideaya-biosciences-partner-to-bring-darovasertib-a-promising-uveal-melanoma-treatment-to-patients-worldwide/ 2025-11-04T03:13:13+00:00 https://acureinsight.org/wp-content/uploads/2025/10/IDEAYA_Logo.jpg https://acureinsight.org/wp-content/uploads/2025/10/IDEAYA_Logo.jpg https://acureinsight.org/prognostic-significance-of-pigmentation-and-stem-cell-markers-in-indian-population-of-uveal-melanoma/ 2025-11-04T03:51:39+00:00 https://acureinsight.org/wp-content/uploads/2025/10/Uveal_Melanoma_prognostic-300x187.jpeg https://acureinsight.org/anniversary-meeting-of-the-society-for-immunotherapy-of-cancer/ 2025-11-12T15:12:30+00:00 https://acureinsight.org/wp-content/uploads/2025/11/ACIS-Research-Coordinator-small.jpg https://acureinsight.org/wp-content/uploads/2025/11/ACIS-Research-Coordinator-742x1024.jpg https://acureinsight.org/acis-summary-of-uveal-melanoma-um-presentations-abstracts-and-posters-at-the-annual-meeting-of-the-european-society-for-medical-oncology-esmo-october-17-21-2025-berlin-germany/ 2025-11-19T02:35:59+00:00 https://acureinsight.org/wp-content/uploads/2025/11/ESMO-A-cure-in-sight.jpg https://acureinsight.org/wp-content/uploads/2025/11/ESMO-A-cure-in-sight.jpg https://acureinsight.org/sir-calls-on-unitedhealthcare-to-expand-access-to-life-saving-radioembolization-treatment/ 2025-11-21T02:51:04+00:00 https://acureinsight.org/wp-content/uploads/2025/11/radiology_business_web.jpg https://acureinsight.org/wp-content/uploads/2025/11/radiology_business_web.jpg https://acureinsight.org/onctura-expands-roginolisib-clinical-trial-program-to-the-u-s-offering-new-hope-for-uveal-melanoma-patients/ 2025-12-01T02:59:39+00:00 https://acureinsight.org/wp-content/uploads/2025/11/ocular-melanoma-a-cure-in-sight-research.jpg https://acureinsight.org/wp-content/uploads/2025/11/ocular-melanoma-a-cure-in-sight-research.jpg https://acureinsight.org/acis-summary-of-uveal-melanoma-presentations-and-abstracts-posters-at-the-society-for-melanoma-research-smr-october-25-28-2025-amsterdam/ 2025-12-05T02:10:27+00:00 https://acureinsight.org/wp-content/uploads/2025/11/society-for-melanoma-a-cure-in-sight.jpg https://acureinsight.org/wp-content/uploads/2025/11/society-for-melanoma-a-cure-in-sight.jpg https://acureinsight.org/a-breakthrough-in-ocular-melanoma-care-new-trilliumbio-oncobit-partnership-expands-access-to-advanced-uveal-melanoma-monitoring-in-the-us/ 2025-12-11T04:05:33+00:00 https://acureinsight.org/wp-content/uploads/2025/12/oncobit-a-cure-insight.jpg https://acureinsight.org/we-are-all-a-little-different-how-a-young-womans-ocular-melanoma-journey-highlights-the-critical-need-for-awareness-support-and-research/ 2025-12-12T04:08:34+00:00 https://acureinsight.org/imiquimod-as-a-novel-topical-treatment-for-ocular-melanoma-and-ossn/ 2025-12-29T16:38:13+00:00 https://acureinsight.org/wp-content/uploads/2025/12/ocular-melanoma-uveal-melanomaSML.jpg https://acureinsight.org/wp-content/uploads/2025/12/ocular-melanoma-uveal-melanomaSML.jpg https://acureinsight.org/early-genetic-evolution-of-ocular-melanoma/ 2025-12-29T16:51:43+00:00 https://acureinsight.org/wp-content/uploads/2025/12/ocular-melanoma-COOG-sml.jpg https://acureinsight.org/wp-content/uploads/2025/12/ocular-melanoma-COOG-sml.jpg https://acureinsight.org/ocular-melanoma-vision-loss-and-access-to-care/ 2025-12-29T17:12:13+00:00 https://acureinsight.org/wp-content/uploads/2025/12/ocular-oncology-ocular-melanoma.jpg https://acureinsight.org/wp-content/uploads/2025/12/ocular-oncology-ocular-melanoma-300x150.jpg https://acureinsight.org/a-cure-in-sight-earns-4-star-charity-navigator-rating-for-ocular-melanoma-impact/ 2025-12-29T17:17:56+00:00 https://acureinsight.org/wp-content/uploads/2025/04/Four-Star-Rating-Badge-Full-Color-1-e1744755076498.png https://acureinsight.org/wp-content/uploads/2025/04/Four-Star-Rating-Badge-Full-Color-1-300x300.png https://acureinsight.org/a-cure-in-sight-launches-groundbreaking-mobile-app-for-ocular-melanoma-patients/ 2025-12-29T17:27:31+00:00 https://acureinsight.org/wp-content/uploads/2025/11/a-cure-in-sight-app.jpg https://acureinsight.org/wp-content/uploads/2025/11/a-cure-in-sight-app-300x238.jpg https://acureinsight.org/acis-announces-2026-swing-for-sight-charity-event-in-wine-country/ 2025-12-30T13:07:40+00:00 https://acureinsight.org/wp-content/uploads/2025/06/swing-for-sight-2026-save-thedate.jpg https://acureinsight.org/wp-content/uploads/2025/06/swing-for-sight-2026-save-thedate-300x200.jpg https://acureinsight.org/metastatic-uveal-melanoma-surveillance-expert-consensus-on-imaging-risk-based-monitoring/ 2025-12-31T14:07:55+00:00 https://acureinsight.org/wp-content/uploads/2025/12/ocular-melanoma-specialty-distribution.webp https://acureinsight.org/living-with-ocular-melanoma/ 2026-01-13T02:59:15+00:00 https://acureinsight.org/wp-content/uploads/2026/01/eye-on-mental-health-ocular-melanoma-ZOOM-banner.jpg https://acureinsight.org/wp-content/uploads/2026/01/eye-on-mental-health-ocular-melanoma-ZOOM-banner.jpg https://acureinsight.org/fda-approved-liver-directed-therapy-shows-consistent-benefit-in-metastatic-uveal-melanoma-review-of-delcaths-phase-3-focus-subgroup-analyses/ 2026-01-18T22:57:54+00:00 https://acureinsight.org/wp-content/uploads/2026/01/delcath_corporate_logo_tagline_Logo.jpg https://acureinsight.org/wp-content/uploads/2026/01/delcath_corporate_logo_tagline_Logo.jpg https://acureinsight.org/ut-southwestern-first-in-texas-to-offer-hepzato-kit-for-metastatic-ocular-melanoma/ 2026-01-18T23:04:53+00:00 https://acureinsight.org/wp-content/uploads/2026/01/treatment-for-rare-eye-cancer.jpg https://acureinsight.org/wp-content/uploads/2026/01/treatment-for-rare-eye-cancer-1024x568.jpg https://acureinsight.org/novel-t-cell-therapy-shows-promise-in-uveal-melanoma/ 2026-01-27T18:01:21+00:00 https://acureinsight.org/wp-content/uploads/2026/01/prame-t-cell-therapy-uveal-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/01/prame-t-cell-therapy-uveal-melanoma.jpg https://acureinsight.org/delcath-systems-phase-3-focus-subgroup-analyses-reinforce-hepzato-kits-role-in-metastatic-uveal-melanoma/ 2026-02-10T19:01:21+00:00 https://acureinsight.org/wp-content/uploads/2026/02/phase3-focus-group-ocular-melanoma-1.jpg https://acureinsight.org/wp-content/uploads/2026/02/phase3-focus-group-ocular-melanoma-300x232.jpg https://acureinsight.org/novelwise-pharma-advances-new-hope-for-metastatic-uveal-melanoma-with-first-patient-dosed-in-nbm-bmx-trial/ 2026-02-02T21:37:13+00:00 https://acureinsight.org/wp-content/uploads/2026/01/metastatic-uvela-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/01/metastatic-uvela-melanoma-300x232.jpg https://acureinsight.org/darovasertib-plus-crizotinib-shows-meaningful-os-gains-in-metastatic-uveal-melanoma-says-dr-orloff/ 2026-02-15T21:38:35+00:00 https://acureinsight.org/wp-content/uploads/2026/01/Metastatic-Uveal-Melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/01/Metastatic-Uveal-Melanoma-300x207.jpg https://acureinsight.org/prame-directed-tcr-therapy-metastatic-uveal-melanoma/ 2026-02-19T14:33:01+00:00 https://acureinsight.org/wp-content/uploads/2026/02/PRAME-directed-TCR-therapy-metastatic-uveal-melanoma.jpg https://acureinsight.org/ocular-nevus-and-ocular-melanoma-risk/ 2026-02-26T13:21:05+00:00 https://acureinsight.org/wp-content/uploads/2026/02/nevus-ocular-melanoma.jpg https://acureinsight.org/stick-with-purpose-using-stickers-to-spread-ocular-melanoma-awareness/ 2026-03-02T17:17:04+00:00 https://acureinsight.org/wp-content/uploads/2026/02/peace-love-cure.jpg https://acureinsight.org/welcoming-chris-to-the-board-of-a-cure-in-sight/ 2026-03-03T16:41:05+00:00 https://acureinsight.org/wp-content/uploads/2026/03/Chris-a-cure-in-sight-2.jpg https://acureinsight.org/wp-content/uploads/2026/03/Chris-a-cure-in-sight-2.jpg https://acureinsight.org/advancing-ocular-melanoma-research-a-cure-in-sight-participates-in-the-mra-scientific-retreat/ 2026-03-15T09:00:59+00:00 https://acureinsight.org/wp-content/uploads/2026/03/MRA-Scientific-Retreat.png https://acureinsight.org/combining-genetic-tests-improves-risk-prediction-in-ocular-melanoma/ 2026-03-20T09:00:42+00:00 https://acureinsight.org/wp-content/uploads/2026/03/Advances-in-ocular-melanoma-research.jpg https://acureinsight.org/wp-content/uploads/2026/03/Advances-in-ocular-melanoma-research.jpg https://acureinsight.org/interferon-alpha-2a-ocular-melanoma-treatment/ 2026-03-11T23:02:21+00:00 https://acureinsight.org/wp-content/uploads/2026/03/Topical-Interferon-Therapy-for-Ocular-Surface-Melanocytic-Disease.jpg https://acureinsight.org/wp-content/uploads/2026/03/Topical-Interferon-Therapy-for-Ocular-Surface-Melanocytic-Disease.jpg https://acureinsight.org/innovative-eye-cancer-treatment-may-eliminate-surgery-for-some-patients-with-iris-melanoma/ 2026-07-03T14:28:29+00:00 https://acureinsight.org/wp-content/uploads/2026/06/uveal-melanoma-iwand.jpg https://acureinsight.org/wp-content/uploads/2026/06/uveal-melanoma-iwand-therapy.jpg https://acureinsight.org/new-research-supports-ruthenium-106-brachytherapy-for-conjunctival-melanoma/ 2026-07-03T18:40:36+00:00 https://acureinsight.org/wp-content/uploads/2026/06/ocular-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/06/ocular-melanoma.jpg https://acureinsight.org/is-every-cancer-a-rare-cancer-a-new-way-of-thinking-about-ocular-melanoma/ 2026-07-07T19:15:33+00:00 https://acureinsight.org/wp-content/uploads/2026/06/clinical-study-ocular-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/06/clinical-study-ocular-melanoma.jpg https://acureinsight.org/asco-2026-brings-encouraging-news-for-patients-with-metastatic-uveal-melanoma/ 2026-07-12T19:41:22+00:00 https://acureinsight.org/wp-content/uploads/2026/06/targeted-oncology-ocular-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/06/targeted-oncology-ocular-melanoma.jpg https://acureinsight.org/new-blood-test-monitoring-tool-offers-additional-insight-for-uveal-melanoma-care/ 2026-07-18T19:55:04+00:00 https://acureinsight.org/wp-content/uploads/2026/06/ocular-melanoma-blood-testing.jpg https://acureinsight.org/wp-content/uploads/2026/06/ocular-melanoma-blood-testing.jpg https://acureinsight.org/new-study-shows-at-home-preparation-for-til-therapy-may-be-safe-for-melanoma-patients/ 2026-07-03T14:28:30+00:00 https://acureinsight.org/wp-content/uploads/2026/06/uveal-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/06/uveal-melanoma.jpg https://acureinsight.org/five-years-later-kimmtrak-continues-to-change-the-outlook-for-metastatic-uveal-melanoma/ 2026-07-03T14:28:30+00:00 https://acureinsight.org/wp-content/uploads/2026/06/Metastatic-Uveal-Melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/06/Metastatic-Uveal-Melanoma.jpg https://acureinsight.org/anzu-cel-cell-therapy-continues-to-show-promise-for-patients-with-metastatic-uveal-melanoma-cloned/ 2026-07-03T14:28:31+00:00 https://acureinsight.org/wp-content/uploads/2026/06/anzu-cel-uveal-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/06/anzu-cel-uveal-melanoma.jpg https://acureinsight.org/new-ctdna-monitoring-test-launches-for-uveal-melanoma-patients/ 2026-07-03T14:28:32+00:00 https://acureinsight.org/wp-content/uploads/2026/05/ctDNA-monitoring-molecular-testing.jpg https://acureinsight.org/wp-content/uploads/2026/05/ctDNA-monitoring-molecular-testing.jpg https://acureinsight.org/new-research-reveals-how-velcrin-drugs-may-kill-cancer-cells-what-it-means-for-ocular-melanoma/ 2026-07-03T14:28:32+00:00 https://acureinsight.org/wp-content/uploads/2026/06/Uveal-Melanoma-Research.jpg https://acureinsight.org/wp-content/uploads/2026/06/Uveal-Melanoma-Research.jpg https://acureinsight.org/aura-biosciences-launches-patient-reported-outcome-study-for-ocular-melanoma-treatment/ 2026-07-03T14:28:33+00:00 https://acureinsight.org/wp-content/uploads/2026/03/choroidal-and-uveal-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/03/choroidal-and-uveal-melanoma.jpg https://acureinsight.org/aacr-2026-ocular-melanoma-research-review/ 2026-07-03T14:28:33+00:00 https://acureinsight.org/wp-content/uploads/2026/05/AACR-2026-annualMeeting-OcularMelanoma.jpg https://acureinsight.org/wp-content/uploads/2026/05/AACR-2026-annualMeeting-OcularMelanoma.jpg https://acureinsight.org/new-mouse-model-brings-researchers-closer-to-understanding-ocular-melanoma/ 2026-07-03T14:28:34+00:00 https://acureinsight.org/wp-content/uploads/2026/03/Moffitt-Study-Creates-More-Realistic-Mouse-Model-of-Eye-Cancer.jpg https://acureinsight.org/wp-content/uploads/2026/03/Moffitt-Study-Creates-More-Realistic-Mouse-Model-of-Eye-Cancer.jpg https://acureinsight.org/liver-directed-therapy-uveal-melanoma/ 2026-07-03T14:28:34+00:00 https://acureinsight.org/wp-content/uploads/2026/04/Delcath-uveal-melanoma-metastatic.jpg https://acureinsight.org/wp-content/uploads/2026/01/delcath_corporate_logo_tagline_Logo.jpg https://acureinsight.org/chopin-trial-shows-promise-for-metastatic-uveal-melanoma-treatment/ 2026-07-03T14:28:35+00:00 https://acureinsight.org/wp-content/uploads/2026/03/Metastatic-Uveal-Melanoma-Treatment.jpg https://acureinsight.org/wp-content/uploads/2026/03/Metastatic-Uveal-Melanoma-Treatment.jpg https://acureinsight.org/patterns-of-spread-in-ocular-melanoma/ 2026-07-03T14:28:36+00:00 https://acureinsight.org/wp-content/uploads/2026/03/Patterns-of-Spread-in-Ocular-Melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/03/Patterns-of-Spread-in-Ocular-Melanoma.jpg https://acureinsight.org/eye-exams-can-detect-ocular-melanoma-diabetes-and-more-early-warning-signs/ 2026-07-03T14:28:36+00:00 https://acureinsight.org/wp-content/uploads/2026/03/Your-Eyes-May-Reveal-Hidden-Health-Risks.jpg https://acureinsight.org/wp-content/uploads/2026/03/Your-Eyes-May-Reveal-Hidden-Health-Risks.jpg https://acureinsight.org/kimmtrak-5-year-survival-data-in-ocular-melanoma-aacr-2026-update/ 2026-07-03T14:28:37+00:00 https://acureinsight.org/wp-content/uploads/2026/03/ocular-melanoma-KIMMTRAK-survival-data.png https://acureinsight.org/wp-content/uploads/2026/03/ocular-melanoma-KIMMTRAK-survival-data.png https://acureinsight.org/rare-disease-week-2026-advocating-for-ocular-melanoma-on-capitol-hill/ 2026-07-03T14:28:37+00:00 https://acureinsight.org/wp-content/uploads/2026/03/rare-disease-day-ocular-melanoma.png https://acureinsight.org/wp-content/uploads/2026/03/rare-disease-day-ocular-melanoma.png https://acureinsight.org/a-cure-in-sight-earns-charity-navigators-2026-four-star-rating/ 2026-07-28T07:00:41+00:00 https://acureinsight.org/wp-content/uploads/2026/07/charity-navigator-a-cure-in-sight.jpg https://acureinsight.org/wp-content/uploads/2026/07/Four-Star-Rating-Badge_2026-300x300.png https://acureinsight.org/hope-beyond-a-rare-diagnosis-one-fathers-uveal-melanoma-journey-shows-the-power-of-clinical-trials/ 2026-07-22T09:08:44+00:00 https://acureinsight.org/wp-content/uploads/2026/07/metastatic-uveal-melanoma-clinical-trial.jpg https://acureinsight.org/wp-content/uploads/2026/07/metastatic-uveal-melanoma-clinical-trial-300x181.jpg https://acureinsight.org/new-research-may-improve-how-doctors-predict-metastasis-risk-in-uveal-melanoma/ 2026-08-03T08:48:15+00:00 https://acureinsight.org/wp-content/uploads/2026/08/uveal-melanoma-metastasis-risk-prediction.jpg https://acureinsight.org/wp-content/uploads/2026/08/uveal-melanoma-metastasis-risk-prediction-300x198.jpg https://acureinsight.org/record-breaking-513-participants-at-the-palo-alto-lookin-for-a-cure-5k/ 2026-07-16T00:19:41+00:00 https://acureinsight.org/wp-content/uploads/2026/07/5K-walks-PaloAlto-2026-sml.jpg https://acureinsight.org/wp-content/uploads/2026/07/5K-walks-PaloAlto-2026-sml-300x194.jpg https://acureinsight.org/new-immunotherapy-research-may-help-strengthen-future-cancer-treatments/ 2026-08-08T08:20:00+00:00 https://acureinsight.org/wp-content/uploads/2026/08/Immunotherapy-Research.jpg https://acureinsight.org/wp-content/uploads/2026/08/Immunotherapy-Research-300x196.jpg https://acureinsight.org/new-targeted-therapy-shows-early-promise-for-metastatic-uveal-melanoma/ 2026-08-12T07:57:02+00:00 https://acureinsight.org/wp-content/uploads/2026/07/Metastatic-Uveal-Melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/07/Metastatic-Uveal-Melanoma-300x194.jpg https://acureinsight.org/advances-in-ocular-oncology-offer-new-hope-for-patients-and-families/ 2026-08-16T09:27:34+00:00 https://acureinsight.org/wp-content/uploads/2026/07/Ocular-Oncology-ocular-melanoma.jpg https://acureinsight.org/wp-content/uploads/2026/07/Ocular-Oncology-ocular-melanoma-300x194.jpg https://acureinsight.org/why-til-immunotherapy-works-for-some-melanoma-patients/ 2026-08-20T15:10:20+00:00 https://acureinsight.org/wp-content/uploads/2026/08/ocularMelanoma-imunotherapy.jpg https://acureinsight.org/wp-content/uploads/2026/08/ocularMelanoma-imunotherapy.jpg